Trial site
Chongqing
- 12running trials
- 7closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia2 trials
- Lupus (SLE)2 trials
- Metastatic breast cancer2 trials
- Multiple sclerosis2 trials
- Myeloproliferative neoplasms2 trials
- Sjögren's disease2 trials
- Spinal muscular atrophy2 trials
- Acute lymphoblastic leukaemia1 trial
- Childhood cancers1 trial
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- Lung cancer1 trial
- and 3 more
- Phase
- Phase 313 trials
- Phase 43 trials
- Phase 22 trials
- Status
- Active, not recruiting8 trials
- Completed7 trials
- Recruiting4 trials
- Lead sponsor
- Novartis Pharmaceuticals19 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Recruiting
Active, not recruiting
Inclisiran Effectiveness in China: a Pragmatic Randomized Trial
Recruiting
Active, not recruiting
Active, not recruiting
Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myeloproliferative neoplasms2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Lupus (SLE)1 recruiting
- Multiple sclerosis1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026